The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 20, 2025
Filed:
Feb. 18, 2022
Applicant:
HK Pharma, San Clemente, CA (US);
Inventors:
Jeffrey Alan Klein, San Juan Capistrano, CA (US);
Paytra Alan Klein, Newport Beach, CA (US);
Assignee:
HK TUMESCENT PHARMA, San Clemente, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/137 (2006.01); A61K 31/167 (2006.01); A61K 31/4164 (2006.01); A61K 31/52 (2006.01); A61K 31/522 (2006.01); A61K 31/546 (2006.01); A61K 45/06 (2006.01); A61K 47/02 (2006.01); A61K 31/56 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 31/137 (2013.01); A61K 31/167 (2013.01); A61K 31/4164 (2013.01); A61K 31/52 (2013.01); A61K 31/522 (2013.01); A61K 31/546 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 31/56 (2013.01);
Abstract
A tumescent composition comprising a biologic drug in a tumescent solution, wherein a tumescent concentration of the biologic drug is simultaneously below a threshold for local, subcutaneous tissue toxicity, above a threshold for positive local therapeutic effect, and above a concentration safely achievable by intravenous (IV), intramuscular (IM) or oral (PO) delivery; and the tumescent solution comprises a vasoconstrictor; a pharmaceutically acceptable carrier; and optionally a local anesthetic.